These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


187 related items for PubMed ID: 8309358

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Characterization of P1-deficient isogenic mutant of Haemophilus influenzae biogroup aegyptius associated with Brazilian purpuric fever.
    Segada LM, Carlone GM, Gheesling LL, Lesse AJ.
    Microb Pathog; 2000 Mar; 28(3):145-55. PubMed ID: 10702356
    [Abstract] [Full Text] [Related]

  • 3. Implications of Haemophilus influenzae biogroup aegyptius hemagglutinins in the pathogenesis of Brazilian purpuric fever.
    Barbosa SF, Hoshino-Shimizu S, Alkmin Md, Goto H.
    J Infect Dis; 2003 Jul 01; 188(1):74-80. PubMed ID: 12825174
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. DNA sequence analysis and restriction fragment length polymorphisms of the P1 gene of Haemophilus influenzae biogroup aegyptius associated with Brazilian purpuric fever.
    Reed RB, Frost JB, Kort K, Myers SD, Lesse AJ.
    Infect Immun; 1996 Sep 01; 64(9):3666-72. PubMed ID: 8751915
    [Abstract] [Full Text] [Related]

  • 9. Emergence and disappearance of a virulent clone of Haemophilus influenzae biogroup aegyptius, cause of Brazilian purpuric fever.
    Harrison LH, Simonsen V, Waldman EA.
    Clin Microbiol Rev; 2008 Oct 01; 21(4):594-605. PubMed ID: 18854482
    [Abstract] [Full Text] [Related]

  • 10. Potential virulence factors of Haemophilus influenzae biogroup aegyptius in Brazilian purpuric fever. The Brazilian Purpuric Fever Study Group.
    Carlone GM, Gorelkin L, Gheesling LL, Hoiseth SK, Mulks MH, O'Connor SP, Weyant RS, Myrick JE, Mayer LW, Arko RJ.
    Pediatr Infect Dis J; 1989 Apr 01; 8(4):245-7. PubMed ID: 2785676
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Role of the 145-kilodalton surface protein in virulence of the Brazilian purpuric fever clone of Haemophilus influenzae biogroup aegyptius for infant rats.
    Rubin LG.
    Infect Immun; 1995 Sep 01; 63(9):3555-8. PubMed ID: 7642291
    [Abstract] [Full Text] [Related]

  • 16. Comparison of lipopolysaccharides from Brazilian purpuric fever isolates and conjunctivitis isolates of Haemophilus influenzae biogroup aegyptius. Brazilian Purpuric Fever Study Group.
    Erwin AL, Munford RS.
    J Clin Microbiol; 1989 Apr 01; 27(4):762-7. PubMed ID: 2786002
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. PBP profiles of Haemophilus influenzae, H. aegyptius, and the H. influenzae biogroup aegyptius associated with Brazilian Purpuric Fever.
    Mendelman PM, Chaffin DO.
    Diagn Microbiol Infect Dis; 1989 Apr 01; 12(5):445-7. PubMed ID: 2612132
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antibody to a 145-kilodalton outer membrane protein has bactericidal activity and protective activity against experimental bacteremia caused by a Brazilian purpuric fever isolate of Haemophilus influenzae biogroup aegyptius. The Brazilian Purpuric Fever Study Group.
    Rubin LG, Rizvi A.
    Infect Immun; 1991 Dec 01; 59(12):4576-82. PubMed ID: 1937817
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.